V. Chopra, S. Anand, S. Krein, C. Chenoweth, and S. Saint, Bloodstream Infection, Venous Thrombosis, and Peripherally Inserted Central Catheters: Reappraising the Evidence, The American Journal of Medicine, vol.125, issue.8, pp.733-774, 2012.
DOI : 10.1016/j.amjmed.2012.04.010

E. Johansson, F. Hammarskjöld, D. Lundberg, and M. Arnlind, Advantages and disadvantages of peripherally inserted central venous catheters (PICC) compared to other central venous lines: A systematic review of the literature, Acta Oncologica, vol.149, issue.5, pp.886-92, 2013.
DOI : 10.1111/j.1538-7836.2010.04126.x

V. Chopra, S. Anand, A. Hickner, M. Buist, M. Rogers et al., Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis, The Lancet, vol.382, issue.9889, pp.311-336, 2013.
DOI : 10.1016/S0140-6736(13)60592-9

V. Chopra, O. Horo, J. Rogers, M. Maki, D. Safdar et al., Conclusions., Infection Control & Hospital Epidemiology, vol.60, issue.09, pp.908-926, 2013.
DOI : 10.1054/clnu.2000.0103

C. Schiffer, P. Mangu, J. Wade, D. Camp-sorrell, D. Cope et al., Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline, Journal of Clinical Oncology, vol.31, issue.10, pp.1357-70, 2013.
DOI : 10.1200/JCO.2012.45.5733

L. Lefebvre, E. Noyon, D. Georgescu, V. Proust, C. Alexandru et al., Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients, Supportive Care in Cancer, vol.15, issue.6, pp.1397-403, 2016.
DOI : 10.1007/s00520-015-2901-8

J. Ferlay, E. Steliarova-foucher, J. Lortet-tieulent, S. Rosso, J. Coebergh et al., Cancer incidence and mortality patterns in Europe: Estimates for 40 countries, 2012.
DOI : 10.1016/j.ejca.2012.12.027

URL : http://doi.org/10.1016/j.ejca.2012.12.027

D. Angelis, R. Sant, M. Coleman, M. Francisci, S. Baili et al., Cancer survival in Europe 1999???2007 by country and age: results of EUROCARE-5???a population-based study, The Lancet Oncology, vol.15, issue.1, pp.23-34, 2014.
DOI : 10.1016/S1470-2045(13)70546-1

E. Senkus, S. Kyriakides, F. Penault-llorca, P. Poortmans, A. Thompson et al., Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.24, pp.7-23, 2013.

A. Nationale-d, Accréditation et d'Evaluation en Santé (ANAES) Evaluation de la qualité de l'utilisation et de la surveillance des chambes à cathéter implantables, 2000.

S. Française-d-'hygiène and . Hospitalière, Prévention des infections associées aux chambres à cathéter implantable pour un accès veineux: recommandations professionnels par consensus formalisé d'experts, pp.1-87, 2012.

C. Klerk, S. Smorenburg, and H. Büller, Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter, Archives of Internal Medicine, vol.163, issue.16, 2003.
DOI : 10.1001/archinte.163.16.1913

S. Française-d-'hygiène and . Hospitalière, Recommandations par consensus formalisé: bonne pratiques et gestion des risques associés au PICC (cathéter central à insertion périphérique), pp.1-124, 2013.

M. Gallieni, M. Pittiruti, and R. Biffi, Vascular Access in Oncology Patients, CA: A Cancer Journal for Clinicians, vol.58, issue.6, pp.323-369, 2008.
DOI : 10.3322/CA.2008.0015

E. Johansson, P. Engervall, H. Björvell, R. Hast, and M. Björkholm, Patients??? perceptions of having a central venous catheter or a totally implantable subcutaneous port system???results from a randomised study in acute leukaemia, Supportive Care in Cancer, vol.7, issue.4 Pt 1, pp.137-180, 2009.
DOI : 10.1007/s00520-008-0449-6

G. Liberale, E. Houkayem, M. Viste, C. Bouazza, F. Moreau et al., Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement, Supportive Care in Cancer, vol.38, issue.12, 2016.
DOI : 10.1007/s00520-016-3368-y

G. Patel, K. Jain, R. Kumar, A. Strickland, L. Pellegrini et al., Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies, Supportive Care in Cancer, vol.23, issue.1, pp.121-129, 2014.
DOI : 10.1007/s00520-013-1941-1

M. Woronoff-lemsi and S. Limat, Marie-Caroline Husson Approche pharmaco-économique : évaluation pharmaco-médico-économique de stratégies thérapeutiques : éléments de méthodologie, pp.2000-2001

V. Riche, Fiche d'économie de la santé n°1 : L'évaluation médico-économique, 2014.

H. Autorité and D. Santé, Guide méthodologique -Choix méthodologiques pour l'évaluation économique à la HAS. Octobre, 2011.

R. Biffi, F. De-braud, F. Orsi, S. Pozzi, S. Mauri et al., Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days, Annals of Oncology, vol.9, issue.7, pp.767-73, 1998.
DOI : 10.1023/A:1008392423469

R. Biffi, S. Pozzi, G. Bonomo, D. Vigna, P. Monfardini et al., Cost Effectiveness of Different Central Venous Approaches for Port Placement and Use in Adult Oncology Patients: Evidence From a Randomized Three-Arm Trial, Annals of Surgical Oncology, vol.99, issue.1, pp.3725-3756, 2014.
DOI : 10.1245/s10434-014-3784-5

D. Periard, P. Monney, G. Waeber, C. Zurkinden, L. Mazzolai et al., Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy, Journal of Thrombosis and Haemostasis, vol.2, issue.Suppl. 3B, pp.1281-1289, 2008.
DOI : 10.1111/j.1538-7836.2008.03053.x

C. Cowl, Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters, Clinical Nutrition, vol.19, issue.4, pp.237-280, 2000.
DOI : 10.1054/clnu.2000.0103

D. Ratz, T. Hofer, S. Flanders, S. Saint, and V. Chopra, CONCLUSION, Infection Control & Hospital Epidemiology, vol.34, issue.07, pp.811-818, 2016.
DOI : 10.1378/chest.12-0923

M. Robinson, K. Mogensen, G. Grudinskas, S. Kohler, and D. Jacobs, Improved Care and Reduced Costs for Patients Requiring Peripherally Inserted Central Catheters: the Role of Bedside Ultrasound and a Dedicated Team, Journal of Parenteral and Enteral Nutrition, vol.29, issue.5, pp.374-383, 2005.
DOI : 10.1053/crad.2001.0843

P. Hernández, J. López, J. Martín, and B. Eguía, Care and cost-utility indicators for high-flow PICC catheters: a study, British Journal of Nursing, vol.20, issue.Sup1, pp.22-29, 2011.
DOI : 10.12968/bjon.2011.20.Sup1.S22

L. Pernar, L. Wolf, A. Seshadri, and V. Patel, Impact of a Surgeon-Led Peripherally Inserted Central Venous Catheter Team on Peripherally Inserted Central Venous Catheter-Related Complications and Costs, Surgical Infections, vol.17, issue.3, pp.352-358, 2016.
DOI : 10.1089/sur.2015.093

M. Fraher, C. Collins, J. Bourke, D. Phelan, and M. Lynch, Cost-effectiveness of employing a total parenteral nutrition surveillance nurse for the prevention of catheter-related bloodstream infections, Journal of Hospital Infection, vol.73, issue.2, pp.129-163, 2009.
DOI : 10.1016/j.jhin.2009.06.005

J. Smith, M. Friedell, M. Cheatham, S. Martin, M. Cohen et al., Peripherally inserted central catheters revisited, The American Journal of Surgery, vol.176, issue.2, pp.208-219, 1998.
DOI : 10.1016/S0002-9610(98)00121-4

H. Viart, C. Combe, T. Martinelli, J. Thomas, and H. Hida, Comparaison entre le co??t d???une pose de cath??ter veineux central d???insertion p??riph??rique et d???une chambre implantable, Annales Pharmaceutiques Fran??aises, vol.73, issue.3, pp.239-283, 2015.
DOI : 10.1016/j.pharma.2014.08.001

. Ameli, fr -Tarifs conventionnels des médecins généralistes en France métropolitaine. http://www.ameli.fr/professionnels-de-sante/medecins/votre-convention/tarifs/tarifsconventionnels-des-medecins-generalistes/tarifs-des-medecins-generalistes-enmetropole .php, 2016.

Y. Yap, C. Karapetis, S. Lerose, S. Iyer, and B. Koczwara, Reducing the risk of peripherally inserted central catheter line complications in the oncology setting, European Journal of Cancer Care, vol.72, issue.4, pp.342-349, 2006.
DOI : 10.1200/JCO.2002.11.135

A. Raiy, B. Fakih, M. Bryan-nomides, N. Hopfner, D. Riegel et al., Peripherally inserted central venous catheters in the acute care setting: A safe alternative to high-risk short-term central venous catheters, American Journal of Infection Control, vol.38, issue.2, pp.149-53, 2010.
DOI : 10.1016/j.ajic.2009.06.008

M. Beckers, H. Ruven, C. Seldenrijk, M. Prins, and D. Biesma, Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer, Thrombosis Research, vol.125, issue.4, pp.318-339, 2010.
DOI : 10.1016/j.thromres.2009.06.008

I. Garajová, G. Nepoti, M. Paragona, G. Brandi, and G. Biasco, Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation, European Journal of Cancer Care, vol.20, issue.1, pp.125-157, 2013.
DOI : 10.1111/ecc.12008

L. Lorente, M. Lecuona, A. Jiménez, J. Cabrera, R. Santacreu et al., Chlorhexidinesilver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy, Am J Infect Control, 2016.
DOI : 10.1016/j.ajic.2016.04.236

U. Frank, T. Chojnacki, M. Dettenkofer, and F. Daschner, Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU, Intensive Care Medicine, vol.29, issue.1, pp.139-139, 2003.
DOI : 10.1007/s00134-002-1559-0

K. Herzer, L. Niessen, D. Constenla, W. Ward, and P. Pronovost, Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA, BMJ Open, vol.4, issue.9, p.6065, 2014.
DOI : 10.1136/bmjopen-2014-006065